Brain β(2)*-nicotinic acetylcholine receptor occupancy after use of a nicotine inhaler

The Nicotrol(®) (Pfizer, USA) nicotine inhaler reduces craving by mimicking the behavioural component of cigarettes and delivering controlled doses of nicotine, which binds to the beta-2 subunit-containing nicotinic acetylcholine receptors (β(2)*-nAChRs). Previous studies examined β(2)*-nAChR occupa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Esterlis, Irina, Mitsis, Effie M., Batis, Jeffery C., Bois, Frederic, Picciotto, Marina R., Stiklus, Stephanie M., Kloczynski, Tracy, Perry, Edward, Seibyl, John P., McKee, Sherry, Staley, Julie K., Cosgrove, Kelly P.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3510008/
https://ncbi.nlm.nih.gov/pubmed/21029513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1461145710001227
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars